Localresistance
Daily review of BTC interval 4HHello everyone, let's look at the BTC to USDT chart on the four hour timeframe. As you can see, the price is moving below the local downtrend line.
Let's start with the support line and as you can see the first support on which the price is currently based is $16663 equal to 0.78 Fib, if the support is broken then the next support is $16419 and $15742.
Now let's move to the resistance line, as you can see the first resistance is $16881, if you manage to break it, the next resistance will be $17107, $17281 and $17462.
Looking at the CHOP indicator, we see that in the four-hour interval, the energy starts to bounce back from the bottom very slowly, the MACD confirms the downtrend, while the RSI is also at the bottom. The indicators presented may indicate a respite.
$SONX Parallel channelB of A Securities Initiates Coverage On Sonendo with Buy Rating, Announces Price Target of $15
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software that integrates digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
$VYNE Support and ResistanceHC Wainwright & Co. Assumes VYNE Therapeutics at Buy, Announces Price Target of $7
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
BTCUSD strong supports are ahead wait for upcoming rise or pumpAs we can see price is now in the blue range zone that is the local range zone and we are waiting for the breakout and then increase in volume after that, But this is not the end, and only after the breakout path is visible that we are going for pump or we are going to retest 30K support zone once again.
Notice: two local resistance (32300, 33300) now are making it hard for the price to start rise and we need confirmation of the upcoming rise by breaking these local resistances.
DISCLAIMER: ((trade based on your own decision ))
<>
CADJPY Short|S/R Flip Retest| Local Resistance| Daily SupportEvening traders,
Today’s Analysis – CADJPY – impulse sell through technical level, rallies are to be sold into as the trend is bearish.
Points to consider,
- Macro trend bearish
- Daily support (immediate target)
- Local resistance (bearish retest)
- Oscillators below 50
- Volume below average
CADJPY’s macro trend is bearish with consecutive lower highs; this gives us a bearish bias on the overall market.
The trends immediate target is daily support, which will be apparent after confirming a bearish retest of local resistance.
Both oscillators are below 50; this signals weakness in the market, further momentum down is likely.
Volume is clearly trading below average; an impulse is most probable at key technical levels i.e. daily support.
Overall in my opinion, a bearish retest will allow for a short trade, risk has to be defined. Price action is to be used upon discretion.
What are your thoughts?
Thank you for following my work!
And remember,
“The four most dangerous words in investing are: This time it's different.” Sir John Templeton